Pays: Royaume-Uni
Langue: anglais
Source: MHRA (Medicines & Healthcare Products Regulatory Agency)
Methyldopa (anhydrous)
Medihealth (Northern) Ltd
C02AB01
Methyldopa (anhydrous)
125mg
Oral tablet
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 02050200